Brief: Medicenna Therapeutics Q2 Loss Per Share C$0.04
13/11/2018 22:53
Medicenna Therapeutics Corp MDNA.TO :
* MEDICENNA REPORTS SECOND QUARTER FISCAL 2019 FINANCIAL
RESULTS
* Q2 LOSS PER SHARE C$0.04
Source text for Eikon: ID:nCNWZJqZ1a
Further company coverage: MDNA.TO
Recent news on Medicenna Therapeutics
See all newsCanada's Medicenna Q1 net loss slightly widens on smaller fair value gain
Brief: Medicenna Therapeutics - Announces Two New U.S. Patents And One Allowed U.S. Patent Application
Brief: Medicenna Announces The Finalization Of The Terms Of Its Public Offering Of Securities
Brief: Medicenna Announces The Launch Of A Marketed Public Offering Of Securities
Brief: Medicenna Therapeutics Appoints Dr. Nageatte Ibrahim As Chief Medical Officer